Aurobindo Moxifloxacin Eye Drops Recall: Impurities Risk Eye Injury
Aurobindo Pharma recalls 0.5% moxifloxacin eye drops due to impurities that could cause eye injury. Affected lots from India, expiring June 2023. Stop using immediately.
Stop using this now
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
Aurobindo Pharma is recalling certain moxifloxacin eye drops because they may contain impurities that could cause eye injury. This affects specific batches made in India with expiration dates up to June 2023. People with prescriptions for these eye drops should stop using them immediately. Read more at govinfonow.com/recall/35386-aurobindo-moxifloxacin-eye-drops-recall-impurities-risk-eye-injury.
Source Summary by GovInfoNow · govinfonow.com/recall/35386-aurobindo-moxifloxacin-eye-drops-recall-impurities-risk-eye-injury · Updated August 18, 2026 · FDA enforcement record: FDA #D-0560-2022
Cite this page
“Aurobindo Moxifloxacin Eye Drops Recall: Impurities Risk Eye Injury.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35386-aurobindo-moxifloxacin-eye-drops-recall-impurities-risk-eye-injury. Based on FDA recall #D-0560-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0560-2022%22&limit=1).
Why it’s dangerous
The eye drops may contain impurities that could cause eye injury. This happens because the medication failed to meet purity standards during manufacturing in India.
Who’s affected
Prescription holders of the affected moxifloxacin eye drops. People with eye conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the 3 mL bottle labeled 'Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, Sterile, Rx Only'. Look for lot numbers CMF210001, CMF210003, or CMF210004 with expiration date June 2023.
- Brand
Aurobindo Pharma- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the affected eye drops if you have them. Do not use the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Aurobindo Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0560-2022 (January 14, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0560-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.